Top Page
ConvaTec
(LSE:CTEC)
ConvaTec (CTEC) vs. iShares MSCI United Kingdom ETF (EWC)
ConvaTec Business Overview & Revenue Model
ConvaTec Financial Statement Overview
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.36B | 2.29B | 2.14B | 2.07B | 2.04B | 1.89B |
| Gross Profit | 1.32B | 1.28B | 1.20B | 1.12B | 1.12B | 1.02B |
| EBITDA | 570.70M | 540.20M | 455.50M | 419.10M | 405.40M | 390.70M |
| Net Income | 216.70M | 190.50M | 130.30M | 62.90M | 117.60M | 112.50M |
Balance Sheet | ||||||
| Total Assets | 3.77B | 3.52B | 3.71B | 3.59B | 3.67B | 3.77B |
| Cash, Cash Equivalents and Short-Term Investments | 95.70M | 64.70M | 98.30M | 145.80M | 463.40M | 565.40M |
| Total Debt | 1.34B | 1.20B | 1.31B | 1.30B | 1.44B | 1.55B |
| Total Liabilities | 1.96B | 1.83B | 2.02B | 1.98B | 1.98B | 2.10B |
| Stockholders Equity | 1.81B | 1.69B | 1.69B | 1.61B | 1.69B | 1.67B |
Cash Flow | ||||||
| Free Cash Flow | 349.60M | 274.10M | 238.20M | 137.50M | 211.80M | 313.30M |
| Operating Cash Flow | 477.70M | 396.20M | 367.40M | 281.70M | 305.90M | 399.50M |
| Investing Cash Flow | -180.90M | -160.80M | -285.70M | -348.30M | -206.50M | -56.30M |
| Financing Cash Flow | -297.60M | -263.80M | -124.00M | -237.10M | -199.90M | -162.10M |
ConvaTec Technical Analysis
ConvaTec Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | £200.62M | 30.17 | 20.31% | 3.48% | 10.80% | 1.75% | |
70 Outperform | £10.31B | 27.96 | 9.30% | 2.35% | 2.51% | 56.56% | |
69 Neutral | £480.17M | 52.24 | 3.66% | 1.25% | 68.03% | -18.27% | |
68 Neutral | £4.59B | 28.74 | 12.73% | 2.11% | 4.18% | 37.65% | |
66 Neutral | £952.04M | 50.19 | 6.75% | 0.67% | 4.00% | -6.98% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
49 Neutral | £5.16M | -4.90 | -5.41% | ― | -20.31% | -19.35% |
ConvaTec Corporate Events
Convatec Group has disclosed its total voting rights as of 31 December 2025, reporting an issued share capital of 2,049,789,559 ordinary shares of 10 pence each, of which 94,937,530 are held in treasury without dividend or voting rights. This leaves 1,954,852,029 voting shares in circulation, a key reference figure for investors monitoring their holdings and regulatory disclosure thresholds under UK financial transparency rules, and it provides the market with clarity on the company’s capital structure at year-end.
The most recent analyst rating on (GB:CTEC) stock is a Buy with a £375.00 price target. To see the full list of analyst forecasts on ConvaTec stock, see the GB:CTEC Stock Forecast page.
ConvaTec Group PLC has completed its share buyback program, purchasing 1,912,745 ordinary shares through UBS AG London Branch, as part of a $300 million initiative announced earlier in August 2025. The shares, bought at an average price of 230.19 pence, will be held in treasury, and this transaction concludes the buyback program, potentially impacting the company’s share value and market positioning.
The most recent analyst rating on (GB:CTEC) stock is a Buy with a £3.25 price target. To see the full list of analyst forecasts on ConvaTec stock, see the GB:CTEC Stock Forecast page.
ConvaTec Group PLC has executed a share buyback transaction, purchasing 3,975,464 ordinary shares as part of its ongoing $300 million share buyback program announced in August 2025. This strategic move, facilitated through UBS AG London Branch, is intended to optimize the company’s capital structure and potentially enhance shareholder value by reducing the number of shares in circulation, which may impact the company’s stock price and voting rights.
The most recent analyst rating on (GB:CTEC) stock is a Buy with a £3.25 price target. To see the full list of analyst forecasts on ConvaTec stock, see the GB:CTEC Stock Forecast page.
ConvaTec Group PLC has executed a share buyback transaction, purchasing 284,667 ordinary shares as part of its $300 million share buyback program announced earlier in August 2025. The purchased shares will be held in treasury, and this move is expected to impact the company’s share capital structure, potentially enhancing shareholder value by reducing the number of shares in circulation.
The most recent analyst rating on (GB:CTEC) stock is a Buy with a £3.25 price target. To see the full list of analyst forecasts on ConvaTec stock, see the GB:CTEC Stock Forecast page.
Convatec Group Plc announced its total voting rights as of November 30, 2025, with an issued share capital comprising over 2 billion ordinary shares, of which approximately 1.96 billion carry voting rights. The company also noted that shares purchased under a buyback program are in the settlement process and will be held in treasury. This update is relevant for shareholders to determine their notification obligations under the FCA’s rules.
The most recent analyst rating on (GB:CTEC) stock is a Buy with a £3.25 price target. To see the full list of analyst forecasts on ConvaTec stock, see the GB:CTEC Stock Forecast page.
ConvaTec Group PLC announced the purchase of 806,991 of its ordinary shares as part of a share buyback program valued up to $300 million. This move, executed through UBS AG London Branch, reflects the company’s strategy to manage its capital structure and potentially enhance shareholder value, with the purchased shares being held in treasury.
The most recent analyst rating on (GB:CTEC) stock is a Buy with a £3.25 price target. To see the full list of analyst forecasts on ConvaTec stock, see the GB:CTEC Stock Forecast page.
ConvaTec Group PLC has announced the purchase of 259,860 ordinary shares as part of its $300 million share buyback program initiated in August 2025. The shares were acquired at a volume-weighted average price of 234.29 pence and will be held in treasury. This move is part of ConvaTec’s strategy to optimize its capital structure and return value to shareholders, potentially enhancing its market position and investor confidence.
The most recent analyst rating on (GB:CTEC) stock is a Buy with a £3.25 price target. To see the full list of analyst forecasts on ConvaTec stock, see the GB:CTEC Stock Forecast page.
ConvaTec Group PLC has executed a share buyback transaction, purchasing 30,024 ordinary shares as part of its $300 million share buyback program announced earlier in August 2025. The shares, acquired through UBS AG London Branch, will be held in treasury, and this move is part of the company’s strategy to manage its capital structure and return value to shareholders. This transaction reflects ConvaTec’s ongoing commitment to optimizing shareholder value and may influence its market position by reducing the number of shares in circulation, potentially impacting share value and investor interest.
The most recent analyst rating on (GB:CTEC) stock is a Buy with a £3.25 price target. To see the full list of analyst forecasts on ConvaTec stock, see the GB:CTEC Stock Forecast page.
ConvaTec Group PLC has executed a share buyback transaction as part of its previously announced $300 million program. The company purchased 237,996 ordinary shares at a volume-weighted average price of 235.49 pence per share, which will be held in treasury. This move is part of ConvaTec’s strategy to manage its capital structure and return value to shareholders, potentially impacting its market positioning and shareholder interests.
The most recent analyst rating on (GB:CTEC) stock is a Buy with a £3.25 price target. To see the full list of analyst forecasts on ConvaTec stock, see the GB:CTEC Stock Forecast page.
ConvaTec Group PLC has executed a share buyback, purchasing 906,241 ordinary shares as part of its $300 million buyback program announced earlier in August 2025. The shares were bought at a volume-weighted average price of 236.32 pence and will be held in treasury, which affects the company’s total voting rights and share capital structure, potentially impacting shareholder calculations under the Financial Conduct Authority’s rules.
The most recent analyst rating on (GB:CTEC) stock is a Buy with a £3.25 price target. To see the full list of analyst forecasts on ConvaTec stock, see the GB:CTEC Stock Forecast page.
ConvaTec Group PLC has executed a share buyback, purchasing 439,326 ordinary shares as part of its $300 million buyback program announced in August 2025. This move is part of the company’s strategy to manage its capital structure effectively, impacting its financial positioning by increasing the number of shares held in treasury and potentially influencing shareholder value.
The most recent analyst rating on (GB:CTEC) stock is a Buy with a £3.25 price target. To see the full list of analyst forecasts on ConvaTec stock, see the GB:CTEC Stock Forecast page.
ConvaTec Group PLC has executed a share buyback program, purchasing 1,454,288 ordinary shares at prices ranging from 236.00 to 238.40 pence per share. This buyback is part of a previously announced $300 million program, with the acquired shares held in treasury. The move is likely to impact the company’s financial structure by reducing the number of shares in circulation, potentially increasing shareholder value.
The most recent analyst rating on (GB:CTEC) stock is a Buy with a £3.25 price target. To see the full list of analyst forecasts on ConvaTec stock, see the GB:CTEC Stock Forecast page.
ConvaTec Group PLC has announced the purchase of 1,398,917 ordinary shares as part of its ongoing share buyback program, which aims to repurchase up to $300 million in shares. This move is part of the company’s strategy to manage its capital structure effectively and return value to shareholders. The shares were acquired at prices ranging from 232.40 to 235.00 pence and will be held in treasury, increasing the company’s total treasury shares to 84,629,928. This transaction reflects ConvaTec’s commitment to enhancing shareholder value and optimizing its financial operations.
The most recent analyst rating on (GB:CTEC) stock is a Buy with a £3.25 price target. To see the full list of analyst forecasts on ConvaTec stock, see the GB:CTEC Stock Forecast page.
ConvaTec Group PLC has announced the repurchase of 3,332,480 ordinary shares as part of its $300 million share buyback program initiated in August 2025. The shares were bought at a volume-weighted average price of 231.60 pence and will be held in treasury, affecting the total voting rights and share calculations for stakeholders.
The most recent analyst rating on (GB:CTEC) stock is a Buy with a £3.25 price target. To see the full list of analyst forecasts on ConvaTec stock, see the GB:CTEC Stock Forecast page.
ConvaTec Group PLC has executed a share buyback program, purchasing 1,640,217 of its ordinary shares through UBS AG London Branch. This move is part of a broader $300 million share buyback initiative announced earlier in August 2025. The shares were acquired at prices ranging from 236.00 to 237.40 pence and will be held in treasury. This transaction increases ConvaTec’s treasury shares to 79,898,531, while the total shares in issue stand at 1,969,891,028. The buyback is expected to enhance shareholder value and reflects the company’s confidence in its financial health.
The most recent analyst rating on (GB:CTEC) stock is a Buy with a £375.00 price target. To see the full list of analyst forecasts on ConvaTec stock, see the GB:CTEC Stock Forecast page.
ConvaTec has reported strong growth driven by new product launches, achieving a 6.3% year-to-date organic revenue growth excluding InnovaMatrix, and is on track to meet its financial targets for FY25. The company anticipates further growth in FY26, with double-digit adjusted EPS growth and operating margin expansion, despite market uncertainties related to InnovaMatrix. ConvaTec continues to expand its product offerings and market presence, securing significant contracts and advancing its innovation pipeline, which positions it well for sustained growth and stakeholder confidence.
The most recent analyst rating on (GB:CTEC) stock is a Buy with a £375.00 price target. To see the full list of analyst forecasts on ConvaTec stock, see the GB:CTEC Stock Forecast page.
ConvaTec Group PLC has executed a significant share buyback, purchasing 2,446,184 ordinary shares as part of its $300 million buyback program announced earlier this year. This move reflects the company’s strategic initiative to enhance shareholder value and optimize its capital structure, potentially impacting its market positioning and stakeholder interests.
The most recent analyst rating on (GB:CTEC) stock is a Buy with a £375.00 price target. To see the full list of analyst forecasts on ConvaTec stock, see the GB:CTEC Stock Forecast page.
ConvaTec Group PLC has executed a share buyback program, purchasing 1,812,238 ordinary shares as part of a previously announced $300 million initiative. The shares, bought at an average price of 236.42 pence, will be held in treasury, impacting the company’s share capital structure and potentially benefiting shareholders by increasing the value of remaining shares.
The most recent analyst rating on (GB:CTEC) stock is a Buy with a £375.00 price target. To see the full list of analyst forecasts on ConvaTec stock, see the GB:CTEC Stock Forecast page.
ConvaTec Group PLC has announced the repurchase of 2,926,541 of its ordinary shares as part of a $300 million share buyback program. This move is part of the company’s strategy to manage its capital structure and return value to shareholders, potentially enhancing its market position and financial stability.
The most recent analyst rating on (GB:CTEC) stock is a Buy with a £375.00 price target. To see the full list of analyst forecasts on ConvaTec stock, see the GB:CTEC Stock Forecast page.
ConvaTec Group PLC has executed a share buyback program, purchasing 2,386,575 ordinary shares at prices ranging from 233.00 to 243.40 pence, as part of its $300 million buyback initiative announced earlier in August 2025. This transaction is expected to enhance shareholder value by reducing the number of shares in circulation, thereby potentially increasing earnings per share and strengthening the company’s market position.
The most recent analyst rating on (GB:CTEC) stock is a Buy with a £340.00 price target. To see the full list of analyst forecasts on ConvaTec stock, see the GB:CTEC Stock Forecast page.
ConvaTec Group PLC has executed a share buyback transaction, purchasing 1,280,162 ordinary shares as part of its previously announced $300 million buyback program. The shares were acquired at a volume-weighted average price of 243.49 pence and will be held in treasury. This move is part of ConvaTec’s strategy to enhance shareholder value and optimize its capital structure, potentially impacting its market positioning and investor relations.
The most recent analyst rating on (GB:CTEC) stock is a Buy with a £340.00 price target. To see the full list of analyst forecasts on ConvaTec stock, see the GB:CTEC Stock Forecast page.
Convatec Group PLC has announced the appointments of Jonny Mason as Chief Executive Officer and Fiona Ryder as Chief Financial Officer. These leadership changes reflect the company’s commitment to building on its recent successful transformation and continuing its focus on innovation and growth. Jonny Mason, who has been with Convatec since 2022, is recognized for his leadership in the company’s turnaround and is expected to drive further growth. Fiona Ryder, with her extensive experience in global finance, will continue to support the company’s strategic goals. These appointments are anticipated to strengthen Convatec’s market position and enhance value for stakeholders.
The most recent analyst rating on (GB:CTEC) stock is a Buy with a £340.00 price target. To see the full list of analyst forecasts on ConvaTec stock, see the GB:CTEC Stock Forecast page.
ConvaTec Group PLC announced the purchase of 2,623,293 ordinary shares as part of its $300 million share buyback program initiated in August 2025. This transaction is intended to enhance shareholder value by reducing the number of shares in circulation, thereby potentially increasing earnings per share and improving the company’s market position.
The most recent analyst rating on (GB:CTEC) stock is a Buy with a £273.00 price target. To see the full list of analyst forecasts on ConvaTec stock, see the GB:CTEC Stock Forecast page.
Convatec has announced its total voting rights as of October 31, 2025, with an issued share capital of 2,049,789,559 ordinary shares, of which 52,991,686 are held in treasury and not considered for dividends or voting. The total number of voting rights is 1,996,797,873, a figure crucial for shareholders under the FCA’s Disclosure and Transparency Rules. Additionally, 10,466,657 shares are in the process of settlement following a share buyback program initiated in August 2025, which will also be held in treasury once settled.
The most recent analyst rating on (GB:CTEC) stock is a Buy with a £273.00 price target. To see the full list of analyst forecasts on ConvaTec stock, see the GB:CTEC Stock Forecast page.
ConvaTec Group PLC has executed a share buyback, purchasing over 2 million ordinary shares as part of its $300 million buyback program announced earlier in August 2025. This strategic move is aimed at consolidating the company’s share capital, potentially enhancing shareholder value and reflecting confidence in its financial health.
The most recent analyst rating on (GB:CTEC) stock is a Buy with a £273.00 price target. To see the full list of analyst forecasts on ConvaTec stock, see the GB:CTEC Stock Forecast page.
ConvaTec Group PLC has executed a share buyback transaction, purchasing over 2.24 million ordinary shares as part of its previously announced $300 million share buyback program. The shares were acquired at prices ranging from 241.20 to 243.80 pence and will be held in treasury. This move is part of ConvaTec’s strategy to optimize its capital structure and return value to shareholders, reflecting confidence in its financial position and future prospects.
The most recent analyst rating on (GB:CTEC) stock is a Buy with a £270.00 price target. To see the full list of analyst forecasts on ConvaTec stock, see the GB:CTEC Stock Forecast page.
ConvaTec Group PLC has executed a share buyback, purchasing 2,372,762 ordinary shares as part of its $300 million buyback program announced earlier in August 2025. The shares were acquired at prices ranging from 242.00 to 246.00 pence and will be held in treasury, impacting the company’s share capital structure and potentially enhancing shareholder value.
The most recent analyst rating on (GB:CTEC) stock is a Buy with a £2.82 price target. To see the full list of analyst forecasts on ConvaTec stock, see the GB:CTEC Stock Forecast page.
ConvaTec Group PLC has executed a share buyback, purchasing 1,560,372 ordinary shares as part of its $300 million share buyback program announced in August 2025. The shares, bought at an average price of 247.41 pence, will be held in treasury, increasing the company’s treasury shares to 54,552,058. This move is likely aimed at enhancing shareholder value and optimizing the company’s capital structure.
The most recent analyst rating on (GB:CTEC) stock is a Buy with a £2.82 price target. To see the full list of analyst forecasts on ConvaTec stock, see the GB:CTEC Stock Forecast page.
Convatec has announced the passing of its CEO, Karim Bitar, who had been on medical leave since August 2025. The company has expressed deep sorrow over the loss and extended condolences to his family. Interim leadership arrangements are currently in place, and further announcements will be made in due course. This development is significant for Convatec as it navigates leadership transitions while maintaining its market position in the medical solutions industry.
The most recent analyst rating on (GB:CTEC) stock is a Buy with a £2.82 price target. To see the full list of analyst forecasts on ConvaTec stock, see the GB:CTEC Stock Forecast page.
ConvaTec Group PLC has executed a share buyback transaction, purchasing 285,122 ordinary shares as part of its $300 million share buyback program announced in August 2025. The shares were bought at prices ranging from 247.00 to 249.00 pence and will be held in treasury. This move is part of ConvaTec’s strategy to optimize its capital structure and return value to shareholders, potentially enhancing its market position and investor confidence.
The most recent analyst rating on (GB:CTEC) stock is a Buy with a £2.82 price target. To see the full list of analyst forecasts on ConvaTec stock, see the GB:CTEC Stock Forecast page.
ConvaTec Group PLC has announced the repurchase of 952,813 ordinary shares as part of its $300 million share buyback program. This strategic move is aimed at optimizing the company’s capital structure and potentially enhancing shareholder value by reducing the number of shares in circulation, thereby increasing earnings per share.
The most recent analyst rating on (GB:CTEC) stock is a Buy with a £2.82 price target. To see the full list of analyst forecasts on ConvaTec stock, see the GB:CTEC Stock Forecast page.
ConvaTec Group PLC has announced the repurchase of 735,364 ordinary shares as part of its ongoing $300 million share buyback program initiated in August 2025. This transaction reflects ConvaTec’s commitment to enhancing shareholder value and optimizing its capital structure, with the purchased shares being held in treasury. The company’s total voting rights now stand at 1,998,035,808 ordinary shares, excluding treasury shares, which may impact shareholder notifications under regulatory guidelines.
The most recent analyst rating on (GB:CTEC) stock is a Buy with a £2.82 price target. To see the full list of analyst forecasts on ConvaTec stock, see the GB:CTEC Stock Forecast page.
ConvaTec Group PLC has executed a share buyback program, purchasing over 1.1 million of its ordinary shares through UBS AG London Branch. This move is part of a previously announced $300 million buyback initiative, aimed at optimizing the company’s capital structure and enhancing shareholder value. The purchased shares will be held in treasury, and the company now holds over 51 million shares in treasury, with nearly 2 billion shares in issue, impacting shareholder voting rights and potentially influencing market perceptions of the company’s financial health.
The most recent analyst rating on (GB:CTEC) stock is a Buy with a £2.82 price target. To see the full list of analyst forecasts on ConvaTec stock, see the GB:CTEC Stock Forecast page.
ConvaTec Group PLC has executed a share buyback, acquiring over one million of its ordinary shares through UBS AG London Branch as part of a $300 million program announced earlier. This move is expected to enhance shareholder value and optimize the company’s capital structure, reflecting confidence in its financial stability and future growth prospects.
The most recent analyst rating on (GB:CTEC) stock is a Buy with a £2.82 price target. To see the full list of analyst forecasts on ConvaTec stock, see the GB:CTEC Stock Forecast page.
ConvaTec Group PLC announced the purchase of 439,212 ordinary shares as part of its $300 million share buyback program initiated in August 2025. This strategic move, executed through UBS AG London Branch, is designed to enhance shareholder value and optimize the company’s capital structure, reflecting ConvaTec’s commitment to returning capital to shareholders.
The most recent analyst rating on (GB:CTEC) stock is a Buy with a £2.82 price target. To see the full list of analyst forecasts on ConvaTec stock, see the GB:CTEC Stock Forecast page.
ConvaTec Group PLC has announced a purchase of 420,064 ordinary shares as part of its ongoing $300 million share buyback program. This move is expected to enhance shareholder value by reducing the number of shares in circulation, thereby potentially increasing earnings per share and reflecting the company’s confidence in its financial position.
The most recent analyst rating on (GB:CTEC) stock is a Buy with a £2.82 price target. To see the full list of analyst forecasts on ConvaTec stock, see the GB:CTEC Stock Forecast page.
ConvaTec Group PLC announced the purchase of 980,727 ordinary shares as part of its $300 million share buyback program initiated in August 2025. This strategic move is intended to enhance shareholder value and optimize the company’s capital structure, reflecting confidence in its financial health and future prospects.
The most recent analyst rating on (GB:CTEC) stock is a Buy with a £2.82 price target. To see the full list of analyst forecasts on ConvaTec stock, see the GB:CTEC Stock Forecast page.
ConvaTec Group PLC has executed a share buyback transaction, purchasing 948,052 ordinary shares as part of its $300 million share buyback program announced in August 2025. The shares were bought at prices ranging between 238.80 and 241.80 pence and will be held in treasury. This move aims to optimize the company’s capital structure and potentially enhance shareholder value by reducing the number of shares in circulation, thereby increasing earnings per share.
The most recent analyst rating on (GB:CTEC) stock is a Buy with a £2.82 price target. To see the full list of analyst forecasts on ConvaTec stock, see the GB:CTEC Stock Forecast page.
ConvaTec Group PLC has executed a share buyback program, purchasing 1,763,576 ordinary shares at prices ranging from 238.00 to 239.80 pence per share, as part of its $300 million buyback initiative announced in August 2025. This strategic move, facilitated through UBS AG London Branch, underscores ConvaTec’s commitment to enhancing shareholder value and optimizing its capital structure, potentially impacting its market positioning and shareholder engagement.
The most recent analyst rating on (GB:CTEC) stock is a Buy with a £3.27 price target. To see the full list of analyst forecasts on ConvaTec stock, see the GB:CTEC Stock Forecast page.
ConvaTec Group PLC has executed a share buyback transaction, acquiring 2,197,889 ordinary shares as part of a previously announced $300 million buyback program. This move is expected to optimize the company’s capital structure and potentially enhance shareholder value by reducing the number of shares in circulation, thereby increasing earnings per share and providing a signal of confidence in the company’s financial health.
The most recent analyst rating on (GB:CTEC) stock is a Buy with a £3.27 price target. To see the full list of analyst forecasts on ConvaTec stock, see the GB:CTEC Stock Forecast page.